Patrick Sheridan

HOPE-TOO Trial Investigators

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers12 papers

Sort

By YearBy Citation

Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study

Ranjit Mohan Anjana,Viswanathan Mohan,Sumathy Rangarajan,Hertzel C Gerstein, Ulagamadesan Venkatesan,Patrick Sheridan,Gilles R Dagenais,Scott A Lear,Koon Teo, Kubilay Karsidag,Khalid F Alhabib,Khalid Yusoff

Diabetes care, no. 12 (2020): 3094-3101

WOSBibtex

Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism

Joel G. Ray,Clive Kearon,Qilong Yi,Patrick Sheridan,Eva Lonn

Annals of Internal Medicine, (2020)

Bibtex

Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries

Balaji Bhavadharini,Mahshid Dehghan,Andrew Mente,Sumathy Rangarajan,Patrick Sheridan,Viswanathan Mohan,Romaina Iqbal,Rajeev Gupta,Scott Lear, Edelweiss Wentzel-Viljoen,Alvaro Avezum,Patricio Lopez-Jaramillo

BMJ open diabetes research & care, no. 1 (2020)

Bibtex

Effect of Rosiglitazone and Ramipril on -Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial

A. J. Hanley,B. Zinman,P. Sheridan,S. Yusuf,H. C. Gerstein

Diabetes Care, no. 3 (2010): 608-613

Cited by53Bibtex

Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

Boyko E J,Gerstein H C,Mohan V,Yusuf S,Sheridan P,Anand S,Shaw J E, Null Null

Diabetic medicine : a journal of the British Diabetic Association, no. 11 (2010): 1226-1232

Cited by15WOSBibtex

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

Dream Trial Investigators,Gilles Dagenais,Hertzel C Gerstein,R R Holman,Andrzej Budaj,Escalante A,Hedner T,Matyas Keltai,Eva Lonn,Samy I Mcfarlane,Matthew J Mcqueen,Koon Teo

Diabetes care, no. 5 (2008): 1007-1014

Cited by159WOSBibtex

Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART)

Claes Held,Glen Sumner,Patrick Sheridan,Mathew McQueen,Sandra Smith,Gilles Dagenais,Salim Yusuf,Eva Lonn

Vascular medicine (London, England), no. 4 (2008): 245-253

Cited by20WOSBibtex

Venous thromboembolism in association with features of the metabolic syndrome

Ray J G,Lonn E,Yi Q,Rathe A,Sheridan P,Kearon C, Null Null,Yusuf S,Arnold M J O,McQueen M J,Pogue J,Probstfield J

QJM : monthly journal of the Association of Physicians, no. 11 (2007): 679-684

Cited by44WOSBibtex

Rosiglitazone Reduced the Incidence of Diabetes in Patients With Impaired Glucose Tolerance

Michael Pignone,Yusuf S,Bosch J,Pogue J,Sheridan P,Mohan V,Shaw J

Clinical Diabetes, no. 1 (2007): 23-24

Cited by2Bibtex

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

Rosiglitazone Medication Trial Investigators,Hertzel C Gerstein,Salim Yusuf,J L H R Bosch,Janice Pogue,Patrick Sheridan,Dinccag N,Markolf Hanefeld,Byron J Hoogwerf,Markku Laakso,Mohan V,Shaw J

Lancet (London, England), no. 9541 (2006): 1096-1105

Cited by1862WOSBibtex

We-W31:5 Homocysteine and folic acid levels and relation to carotid atherosclerosis in high-risk individuals

C. Held,G. Sumner,P. Sheridan,M. McQueen,S. Smith,S. Yusuf,E. Lonn

Atherosclerosis (Supplements) (Component), no. 3 (2006): 308-308

EIBibtex

Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial

Lonn E,Held C,Arnold J M O,Probstfield J,McQueen M,Micks M,Pogue J,Sheridan P,Bosch J,Genest J,Yusuf S, Null Null

Canadian Journal of Cardiology, no. 1 (2006): 47-53

Cited by23WOSBibtex

View All

Base Info Papers Patents Projects